These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND hCG AND Diagnosis
13 results:

  • 1. [Clinicopathological analysis of lung metastatic tumor].
    Lou N; Niu YR; Yang F; Lu ZH
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1039-1044. PubMed ID: 34496496
    [No Abstract]    [Full Text] [Related]  

  • 2. A rare case of primary rectal choriocarcinoma and review of the literature.
    Telli TA; Demircan NC; Alan O; Tuylu TB; Arikan R; Ercelep O; Atıcı AE; Ergelen R; Seven IE; Babacan NA; Kaya S; Dane F; Fulden Yumuk P
    J Oncol Pharm Pract; 2020 Jun; 26(4):989-994. PubMed ID: 31547751
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discrepant serum and urine β-hcg results due to production of β-hcg by a cribriform-morular variant of thyroid papillary carcinoma.
    Alikhan M; Koshy A; Hyjek E; Stenson K; Cohen RN; Yeo KT
    Clin Chim Acta; 2015 Jan; 438():181-5. PubMed ID: 25181612
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement.
    Chen C; Chen LQ; Yang GL; Li Y
    J Postgrad Med; 2008; 54(3):186-90. PubMed ID: 18626164
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CEA, CA 242, CA 19-9, CA 72-4 and hcgbeta in the diagnosis of recurrent colorectal cancer.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
    Canil CM; Tannock IF
    Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Tumor markers--personal experience. A case report of primary lung cancer with interesting production of tumor markers].
    Ariyoshi Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1721-5. PubMed ID: 1872630
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Human chorionic gonadotropin-like substance (hcgLS) in male patients with gastrointestinal cancer].
    Ohyama Y
    Nihon Geka Gakkai Zasshi; 1986 Jan; 87(1):20-8. PubMed ID: 2421150
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adenocarcinoma of the colon with syncytiotrophoblastic differentiation: differential diagnosis and implications.
    Metz KA; Richter HJ; Leder LD
    Pathol Res Pract; 1985 Jan; 179(3):419-24. PubMed ID: 4039056
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Human chorionic gonadotropin immunoreactivity in serum of patients with malignant neoplasms.
    Ayala AR; Saad A; Vázquez X; Ramírez-Wiella G; Perches RD
    Am J Reprod Immunol (1980); 1983; 3(3):149-51. PubMed ID: 6869651
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.